StructuralAspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial
Graphical abstract
Key Words
Abbreviations and Acronyms
Cited by (0)
This trial was supported by a grant from Edwards Lifesciences and by a grant from the Foundation of the Research Center of the Quebec Heart & Lung Institute. Drs. Rodés-Cabau and Webb have received research grants from Edwards Lifesciences. Dr. Welsh has received research grants and personal fees from AstraZeneca, Amgen, Bayer, Janssen, Bristol-Myers Squibb/Pfizer, and Edwards Lifesciences; and research grants from Boehringer Ingelheim. Drs. Masson and Généreux are consultants for Edwards Lifesciences. Dr. Chamandi has received fellowship grant support from Edwards Lifesciences. Dr. Thoenes is an employee of Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.